A role of the polysynaptic system of substantia nigra in the cholinergic-dopaminergic equilibrium in the central nervous system.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D002217:Carbachol / Q000494:pharmacology; D002490:Central Nervous System / Q000502:physiology*; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism / Q000502:physiology*; D004569:Electroencephalography; D006719:Homovanillic Acid / Q000378:metabolism; D008297:Male; D010275:Parasympathetic Nervous System / Q000502:physiology*; D011817:Rabbits; D013378:Substantia Nigra / Q000502:physiology*; D013569:Synapses / Q000502:physiology*
D002217:Carbachol; D001058:Apomorphine; D004298:Dopamine; D006719:Homovanillic Acid